CompletedNCT01446406
Official study titleElectronic Daily Self-monitoring of Subjective and Objective Symptoms in Bipolar Disorder - The MONARCA Project (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes)
This study has finished and is no longer accepting participants.
In CopenhagenBipolarityDevice studyAges 18–60
- Countries
- Denmark
- Sponsor
- Psychiatric Centre Rigshospitalet
CompletedNCT01575561
Official study titleA Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including DothanBipolarityMedication studyAges 18+
- Countries
- United States, France, Argentina, + 9 others
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT02970721
Official study titleUse of Psychotropic Medications Among Pregnant Women With Bipolar Disorder: Patterns, Determinants, and Impact on Perinatal Outcomes
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityObservational studyAges 15–50
- Countries
- Sponsor
- Western University, Canada
CompletedNCT03259555
What is this study about?Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockBipolarityMedication studyAges 18–65
- Countries
- United States, Bulgaria, Poland, + 1 other
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
TerminatedNCT00732251
Official study titleAn Open Label, Naturalistic Study With Allopurinol Augmentation for Prevention of Mania in Bipolar Disorder
This study ended early.
In Los AngelesBipolarityMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Cedars-Sinai Medical Center